CN Stock MarketDetailed Quotes

002422 Sichuan Kelun Pharmaceutical

Watchlist

36.21
+3.29+9.99%

Market Closed Apr 30 15:00 CST

57.87BMarket Cap23.20P/E (TTM)

Sichuan Kelun Pharmaceutical Key Stats

Cash Flow

All

YOY

Hide blank lines

(Q3)Mar 31, 2025

(FY)Dec 31, 2024

(Q9)Sep 30, 2024

(Q6)Jun 30, 2024

(Q3)Mar 31, 2024

(FY)Dec 31, 2023

(Q9)Sep 30, 2023

(Q6)Jun 30, 2023

(Q3)Mar 31, 2023

(FY)Dec 31, 2022

Assets

Current assets

Money funds

-34.92%4.09B

-15.01%3.97B

-16.51%5.13B

37.39%6.11B

5.87%6.29B

-1.13%4.68B

80.16%6.14B

36.21%4.45B

13.67%5.94B

61.97%4.73B

Transactional financial assets

311.33%2.23B

13.61%1.92B

144.01%1.96B

-31.07%1.02B

-12.79%542.45M

277.38%1.69B

-27.60%801.72M

77.48%1.48B

297.68%622M

24.64%448.11M

Notes receivable and accounts receivable

-4.89%4.73B

2.40%4.8B

-4.71%4.73B

-14.70%4.72B

-13.64%4.97B

-17.80%4.68B

-11.18%4.97B

-0.22%5.53B

0.08%5.75B

7.46%5.7B

-Accounts receivable

-4.89%4.73B

2.40%4.8B

-4.71%4.73B

-14.70%4.72B

-13.64%4.97B

-17.80%4.68B

-11.18%4.97B

-0.22%5.53B

0.08%5.75B

7.46%5.7B

Other receivables (including interest and dividends)

-1.58%186.48M

-22.35%126.17M

-12.70%185.4M

-11.57%181.79M

-29.24%189.48M

-36.60%162.49M

-13.97%212.36M

-13.31%205.59M

7.68%267.78M

15.50%256.3M

-Dividend receivable

----

--10.36M

--9.97M

--15.21M

----

3.24%7.22M

-Accrued interest receivable

6.97%4.84M

7.09%4.76M

-71.80%4.68M

-32.61%4.6M

-14.24%4.52M

-14.79%4.44M

221.40%16.6M

35.67%6.83M

1.93%5.27M

2.14%5.22M

-Other receivable

----

-29.74%111.05M

--170.74M

-18.50%161.99M

----

-35.19%158.05M

----

-14.37%198.76M

----

16.23%243.87M

Advance payment

-26.17%380.63M

-0.74%383.49M

-7.02%664.3M

-9.44%416.4M

-9.96%515.56M

-10.47%386.36M

-5.24%714.42M

-9.29%459.8M

20.19%572.57M

5.08%431.54M

Inventories

8.23%3.83B

-1.02%3.8B

6.92%3.29B

3.78%3.25B

12.41%3.54B

19.47%3.84B

3.90%3.08B

-1.04%3.13B

-5.85%3.15B

-4.43%3.21B

Receivable financing

-24.59%1.41B

-9.34%1.3B

38.03%1.67B

44.10%1.8B

12.91%1.87B

-4.26%1.44B

-19.14%1.21B

6.33%1.25B

74.69%1.66B

29.14%1.5B

Other current assets

26.17%1.63B

15.40%1.63B

162.74%1.44B

246.12%1.43B

206.09%1.29B

279.59%1.41B

167.47%546.39M

136.90%414.54M

80.48%422.27M

37.67%372.68M

Total current assets

-3.75%18.49B

-1.94%17.94B

7.88%19.07B

11.88%18.93B

4.48%19.21B

9.85%18.29B

12.04%17.67B

13.56%16.92B

12.22%18.39B

18.85%16.65B

Non Current assets

Other equity investment

56.18%63.67M

158.34%40.74M

171.54%40.77M

5.03%15.77M

0.00%15.01M

0.09%15.01M

--15.01M

Other non-current financial assets

--30M

----

Long-term equity investment

6.01%4.28B

5.87%4.21B

3.19%4.14B

2.17%4.06B

5.26%4.04B

4.81%3.98B

7.20%4.01B

10.45%3.98B

9.61%3.84B

11.30%3.79B

Fixed assets

----

2.97%9.97B

----

-3.77%9.75B

----

-6.15%9.69B

----

-4.97%10.13B

Constru in process

----

54.49%2.29B

----

81.63%2.04B

----

41.81%1.48B

----

22.01%1.13B

Construction materials

----

0.00%71.66K

Intangible assets

-2.17%1.23B

-4.23%1.22B

-0.51%1.22B

0.47%1.24B

2.88%1.26B

6.30%1.28B

8.86%1.23B

13.03%1.23B

12.15%1.22B

13.03%1.2B

Development expenditure

-43.85%7.36M

-67.81%6.36M

-90.18%8.92M

-88.82%13.27M

-90.97%13.11M

-87.47%19.77M

-60.35%90.86M

-58.25%118.65M

-49.26%145.18M

-50.44%157.77M

Goodwill

0.00%98.66M

Long deferred expense

-14.49%74.82M

37.08%76.7M

30.14%81.53M

39.68%85.58M

35.42%87.5M

-26.42%55.95M

-8.59%62.64M

16.28%61.27M

42.09%64.61M

62.04%76.04M

Deferred tax assets

22.08%432.94M

23.49%423.03M

-43.45%390.64M

-46.03%370.51M

-43.34%354.63M

-44.59%342.57M

9.44%690.83M

8.39%686.45M

3.70%625.9M

6.30%618.21M

Usufruct assets

107.36%612.34M

117.24%631.6M

137.04%645.83M

129.59%623.96M

11.10%295.31M

296.67%290.74M

454.41%272.46M

429.67%271.77M

767.51%265.81M

150.22%73.3M

Other non current assets

-25.30%227.65M

-11.28%260.11M

-17.97%348.05M

-10.89%319.74M

1.29%304.74M

10.91%293.17M

-10.54%424.3M

-25.16%358.82M

-33.35%300.86M

-33.92%264.34M

Total non current assets

4.71%19.34B

6.69%19.38B

5.69%19.33B

6.27%19.11B

4.22%18.47B

3.47%18.16B

3.22%18.29B

1.79%17.98B

0.79%17.72B

0.15%17.56B

Total assets

0.40%37.83B

2.36%37.32B

6.76%38.39B

8.99%38.04B

4.35%37.68B

6.57%36.45B

7.37%35.96B

7.17%34.9B

6.30%36.11B

8.45%34.21B

Liabilities

Current liabilities

Short term loan

-5.33%3.09B

-28.95%2.46B

-19.25%2.59B

-3.85%3.18B

-13.30%3.26B

5.09%3.46B

-11.39%3.21B

3.94%3.31B

10.70%3.76B

-2.28%3.29B

Transactional financial liabilities

----

-93.96%256.1K

-49.14%551.43K

--31.5K

-77.66%665.89K

316.82%4.24M

--1.08M

----

Notes payable and accounts payable

-5.04%2.44B

1.40%2.57B

8.49%2.44B

16.77%2.61B

25.18%2.57B

13.12%2.54B

9.87%2.25B

16.73%2.23B

6.91%2.05B

4.10%2.24B

-Notes payable

-18.38%416.84M

-45.13%205.63M

32.36%216.51M

69.51%347.86M

266.60%510.7M

57.61%374.75M

-52.03%163.57M

3.89%205.22M

-37.47%139.31M

-34.27%237.78M

-Accounts payable

-1.73%2.02B

9.45%2.37B

6.61%2.22B

11.44%2.26B

7.59%2.06B

7.85%2.16B

22.26%2.08B

18.21%2.03B

12.74%1.91B

11.84%2.01B

Contract liabilities

-14.71%485.39M

-24.57%539.51M

-71.47%237.14M

-82.37%169.94M

-43.59%569.1M

98.48%715.24M

192.11%831.15M

495.59%964.15M

324.22%1.01B

36.15%360.36M

Salaries payable

53.18%307.45M

101.64%621.21M

95.30%444.55M

11.50%225.09M

19.98%200.71M

21.35%308.08M

65.05%227.63M

51.67%201.88M

125.72%167.29M

94.41%253.87M

Taxs payable

-44.24%245.37M

-13.85%238.59M

22.17%284.07M

16.15%254.03M

79.22%440.02M

0.87%276.94M

-29.56%232.53M

-32.17%218.72M

-11.14%245.52M

17.91%274.57M

Other payable (including interest and dividends)

-17.80%1.72B

-3.66%1.82B

34.20%2.47B

-43.78%2.16B

-45.72%2.09B

-22.09%1.88B

-21.20%1.84B

72.79%3.84B

78.00%3.86B

9.80%2.42B

-Dividend payable

----

-97.04%41.9K

29,108.86%413.66M

-97.59%35.4K

--1.4M

--1.42M

--1.47M

----

-Other payable

----

-43.76%2.16B

----

-22.15%1.88B

----

72.72%3.83B

----

9.80%2.42B

Non current liabilities due within one year

48.42%790.41M

10.61%870.96M

-18.40%748.86M

-58.55%417.38M

-51.12%532.55M

-61.20%787.39M

-50.99%917.7M

-42.96%1.01B

-33.74%1.09B

-36.79%2.03B

Other current liabilities

-37.62%15.96M

-12.75%20.64M

3,130.06%926.48M

38.15%618.59M

-96.92%25.58M

-98.08%23.65M

-98.25%28.68M

-72.69%447.77M

-68.71%830.93M

-33.17%1.23B

Total current liabilities

-6.19%9.09B

-8.56%9.14B

6.35%10.14B

-21.19%9.63B

-25.52%9.69B

-17.44%9.99B

-22.29%9.54B

7.77%12.22B

5.18%13.01B

-9.73%12.1B

Current liabilities

Long term loan

-84.86%196M

-68.40%342M

-40.93%888.95M

-9.29%1.36B

-29.64%1.29B

-46.83%1.08B

-42.59%1.5B

-54.75%1.5B

-51.23%1.84B

-41.94%2.04B

Bonds payable

----

-99.91%1.71M

-41.31%1.57B

-29.68%1.92B

-29.65%1.9B

-27.51%1.94B

--2.67B

Estimate liabilities

115.63%3.04M

----

2.64%5.47M

-5.84%3.22M

-43.84%1.41M

--77.9K

--5.33M

--3.41M

--2.51M

----

Deferred tax liabilities

4.53%278.96M

0.75%266.09M

-14.24%272.9M

-17.59%268.67M

1.13%266.86M

-0.65%264.1M

24.10%318.21M

26.66%326.01M

1.59%263.87M

4.53%265.83M

Long term deferred income

3.26%299.51M

2.24%294.65M

22.20%292.04M

38.77%301.99M

43.46%290.06M

37.97%288.21M

16.50%238.98M

1.93%217.62M

-8.47%202.2M

-7.46%208.88M

Lease liabilities

104.57%525.26M

119.17%537.46M

140.72%558.84M

127.97%537.32M

2.96%256.77M

373.97%245.23M

615.92%232.16M

605.57%235.69M

1,512.49%249.39M

219.72%51.74M

Other non current liabilities

----

--0

Total non current liabilities

-38.31%1.3B

-58.21%1.44B

-52.12%2.02B

-40.86%2.48B

-53.04%2.11B

-34.12%3.45B

-27.81%4.22B

-35.88%4.19B

-35.24%4.5B

30.70%5.23B

Total liabilities

-11.93%10.4B

-21.29%10.58B

-11.57%12.16B

-26.21%12.11B

-32.59%11.8B

-22.47%13.44B

-24.07%13.75B

-8.18%16.41B

-9.35%17.51B

-0.43%17.33B

Shareholders equity

Paid-in capital

-0.22%1.6B

6.83%1.6B

8.58%1.6B

8.86%1.6B

5.40%1.5B

4.10%1.48B

3.48%1.48B

3.22%1.47B

-0.22%1.42B

Other equity instruments

----

-43.38%170.22M

-32.19%210.06M

-32.19%210.07M

-30.17%216.34M

--300.63M

Capital reserve funds

-0.77%7.71B

25.85%7.73B

45.56%8.3B

115.98%8.28B

109.34%7.77B

67.27%6.14B

81.10%5.7B

11.89%3.83B

3.59%3.71B

2.56%3.67B

Surplus reserve funds

14.11%1.62B

15.42%1.42B

15.41%1.42B

15.38%1.23B

Retained profit

5.25%12.19B

9.94%11.6B

10.61%11.34B

14.10%11.08B

15.57%11.58B

14.88%10.55B

12.95%10.25B

13.82%9.71B

17.14%10.02B

11.19%9.19B

Less:Treasury stock

-38.34%131.7M

-10.83%191.83M

-10.40%192.98M

-9.90%213.61M

-9.25%215.14M

-27.43%215.38M

-52.88%215.38M

-40.73%237.08M

Other composite income

8.02%105.18M

14.34%112.99M

-63.08%84.9M

-51.22%118.97M

-12.26%97.38M

-37.92%98.82M

25.20%229.95M

587.72%243.89M

214.58%110.99M

305.45%159.19M

Specific reserves

-2.06%2.91M

-5.92%2.85M

--2.76M

--2.89M

--2.97M

--3.02M

----

Shareholders equity without minority interests

3.75%23.09B

14.27%22.48B

19.45%22.56B

35.30%22.31B

34.72%22.26B

25.03%19.67B

26.70%18.88B

15.00%16.49B

14.41%16.52B

13.55%15.73B

Minority interests

20.06%4.34B

27.38%4.26B

10.59%3.68B

80.70%3.62B

74.35%3.61B

194.11%3.34B

600.18%3.32B

458.48%2.01B

905.02%2.07B

316.97%1.14B

Total shareholder equity

6.02%27.43B

16.17%26.74B

18.12%26.23B

40.23%25.93B

39.13%25.87B

36.42%23.02B

44.40%22.21B

25.84%18.49B

26.95%18.6B

19.40%16.87B

Total liabilityies and equity

0.40%37.83B

2.36%37.32B

6.76%38.39B

8.99%38.04B

4.35%37.68B

6.57%36.45B

7.37%35.96B

7.17%34.9B

6.30%36.11B

8.45%34.21B

Currency Unit

CNY

Accounting Standards

CAS (2007)

Audit Opinions

Unqualified opinion

Auditor

Tianjian Certified Public Accountants (Special General Partnership)

KPMG Huazhen Certified Public Accountants (Special General Partnership)

	(Q3)Mar 31, 2025	(FY)Dec 31, 2024	(Q9)Sep 30, 2024	(Q6)Jun 30, 2024	(Q3)Mar 31, 2024	(FY)Dec 31, 2023	(Q9)Sep 30, 2023	(Q6)Jun 30, 2023	(Q3)Mar 31, 2023	(FY)Dec 31, 2022
Assets
Current assets
Money funds	-34.92%4.09B	-15.01%3.97B	-16.51%5.13B	37.39%6.11B	5.87%6.29B	-1.13%4.68B	80.16%6.14B	36.21%4.45B	13.67%5.94B	61.97%4.73B
Transactional financial assets	311.33%2.23B	13.61%1.92B	144.01%1.96B	-31.07%1.02B	-12.79%542.45M	277.38%1.69B	-27.60%801.72M	77.48%1.48B	297.68%622M	24.64%448.11M
Notes receivable and accounts receivable	-4.89%4.73B	2.40%4.8B	-4.71%4.73B	-14.70%4.72B	-13.64%4.97B	-17.80%4.68B	-11.18%4.97B	-0.22%5.53B	0.08%5.75B	7.46%5.7B
-Accounts receivable	-4.89%4.73B	2.40%4.8B	-4.71%4.73B	-14.70%4.72B	-13.64%4.97B	-17.80%4.68B	-11.18%4.97B	-0.22%5.53B	0.08%5.75B	7.46%5.7B
Other receivables (including interest and dividends)	-1.58%186.48M	-22.35%126.17M	-12.70%185.4M	-11.57%181.79M	-29.24%189.48M	-36.60%162.49M	-13.97%212.36M	-13.31%205.59M	7.68%267.78M	15.50%256.3M
-Dividend receivable	----	--10.36M	--9.97M	--15.21M	----	----	----	----	----	3.24%7.22M
-Accrued interest receivable	6.97%4.84M	7.09%4.76M	-71.80%4.68M	-32.61%4.6M	-14.24%4.52M	-14.79%4.44M	221.40%16.6M	35.67%6.83M	1.93%5.27M	2.14%5.22M
-Other receivable	----	-29.74%111.05M	--170.74M	-18.50%161.99M	----	-35.19%158.05M	----	-14.37%198.76M	----	16.23%243.87M
Advance payment	-26.17%380.63M	-0.74%383.49M	-7.02%664.3M	-9.44%416.4M	-9.96%515.56M	-10.47%386.36M	-5.24%714.42M	-9.29%459.8M	20.19%572.57M	5.08%431.54M
Inventories	8.23%3.83B	-1.02%3.8B	6.92%3.29B	3.78%3.25B	12.41%3.54B	19.47%3.84B	3.90%3.08B	-1.04%3.13B	-5.85%3.15B	-4.43%3.21B
Receivable financing	-24.59%1.41B	-9.34%1.3B	38.03%1.67B	44.10%1.8B	12.91%1.87B	-4.26%1.44B	-19.14%1.21B	6.33%1.25B	74.69%1.66B	29.14%1.5B
Other current assets	26.17%1.63B	15.40%1.63B	162.74%1.44B	246.12%1.43B	206.09%1.29B	279.59%1.41B	167.47%546.39M	136.90%414.54M	80.48%422.27M	37.67%372.68M
Total current assets	-3.75%18.49B	-1.94%17.94B	7.88%19.07B	11.88%18.93B	4.48%19.21B	9.85%18.29B	12.04%17.67B	13.56%16.92B	12.22%18.39B	18.85%16.65B
Non Current assets
Other equity investment	56.18%63.67M	158.34%40.74M	171.54%40.77M	171.54%40.77M	171.54%40.77M	5.03%15.77M	0.00%15.01M	0.00%15.01M	0.09%15.01M	--15.01M
Other non-current financial assets	--30M	--30M	----	----	----	----	----	----	----	----
Long-term equity investment	6.01%4.28B	5.87%4.21B	3.19%4.14B	2.17%4.06B	5.26%4.04B	4.81%3.98B	7.20%4.01B	10.45%3.98B	9.61%3.84B	11.30%3.79B
Fixed assets	----	----	----	2.97%9.97B	----	-3.77%9.75B	----	-6.15%9.69B	----	-4.97%10.13B
Constru in process	----	----	----	54.49%2.29B	----	81.63%2.04B	----	41.81%1.48B	----	22.01%1.13B
Construction materials	----	----	----	----	----	----	----	----	----	0.00%71.66K
Intangible assets	-2.17%1.23B	-4.23%1.22B	-0.51%1.22B	0.47%1.24B	2.88%1.26B	6.30%1.28B	8.86%1.23B	13.03%1.23B	12.15%1.22B	13.03%1.2B
Development expenditure	-43.85%7.36M	-67.81%6.36M	-90.18%8.92M	-88.82%13.27M	-90.97%13.11M	-87.47%19.77M	-60.35%90.86M	-58.25%118.65M	-49.26%145.18M	-50.44%157.77M
Goodwill	0.00%98.66M	0.00%98.66M	0.00%98.66M	0.00%98.66M	0.00%98.66M	0.00%98.66M	0.00%98.66M	0.00%98.66M	0.00%98.66M	0.00%98.66M
Long deferred expense	-14.49%74.82M	37.08%76.7M	30.14%81.53M	39.68%85.58M	35.42%87.5M	-26.42%55.95M	-8.59%62.64M	16.28%61.27M	42.09%64.61M	62.04%76.04M
Deferred tax assets	22.08%432.94M	23.49%423.03M	-43.45%390.64M	-46.03%370.51M	-43.34%354.63M	-44.59%342.57M	9.44%690.83M	8.39%686.45M	3.70%625.9M	6.30%618.21M
Usufruct assets	107.36%612.34M	117.24%631.6M	137.04%645.83M	129.59%623.96M	11.10%295.31M	296.67%290.74M	454.41%272.46M	429.67%271.77M	767.51%265.81M	150.22%73.3M
Other non current assets	-25.30%227.65M	-11.28%260.11M	-17.97%348.05M	-10.89%319.74M	1.29%304.74M	10.91%293.17M	-10.54%424.3M	-25.16%358.82M	-33.35%300.86M	-33.92%264.34M
Total non current assets	4.71%19.34B	6.69%19.38B	5.69%19.33B	6.27%19.11B	4.22%18.47B	3.47%18.16B	3.22%18.29B	1.79%17.98B	0.79%17.72B	0.15%17.56B
Total assets	0.40%37.83B	2.36%37.32B	6.76%38.39B	8.99%38.04B	4.35%37.68B	6.57%36.45B	7.37%35.96B	7.17%34.9B	6.30%36.11B	8.45%34.21B
Liabilities
Current liabilities
Short term loan	-5.33%3.09B	-28.95%2.46B	-19.25%2.59B	-3.85%3.18B	-13.30%3.26B	5.09%3.46B	-11.39%3.21B	3.94%3.31B	10.70%3.76B	-2.28%3.29B
Transactional financial liabilities	----	----	----	-93.96%256.1K	-49.14%551.43K	--31.5K	-77.66%665.89K	316.82%4.24M	--1.08M	----
Notes payable and accounts payable	-5.04%2.44B	1.40%2.57B	8.49%2.44B	16.77%2.61B	25.18%2.57B	13.12%2.54B	9.87%2.25B	16.73%2.23B	6.91%2.05B	4.10%2.24B
-Notes payable	-18.38%416.84M	-45.13%205.63M	32.36%216.51M	69.51%347.86M	266.60%510.7M	57.61%374.75M	-52.03%163.57M	3.89%205.22M	-37.47%139.31M	-34.27%237.78M
-Accounts payable	-1.73%2.02B	9.45%2.37B	6.61%2.22B	11.44%2.26B	7.59%2.06B	7.85%2.16B	22.26%2.08B	18.21%2.03B	12.74%1.91B	11.84%2.01B
Contract liabilities	-14.71%485.39M	-24.57%539.51M	-71.47%237.14M	-82.37%169.94M	-43.59%569.1M	98.48%715.24M	192.11%831.15M	495.59%964.15M	324.22%1.01B	36.15%360.36M
Salaries payable	53.18%307.45M	101.64%621.21M	95.30%444.55M	11.50%225.09M	19.98%200.71M	21.35%308.08M	65.05%227.63M	51.67%201.88M	125.72%167.29M	94.41%253.87M
Taxs payable	-44.24%245.37M	-13.85%238.59M	22.17%284.07M	16.15%254.03M	79.22%440.02M	0.87%276.94M	-29.56%232.53M	-32.17%218.72M	-11.14%245.52M	17.91%274.57M
Other payable (including interest and dividends)	-17.80%1.72B	-3.66%1.82B	34.20%2.47B	-43.78%2.16B	-45.72%2.09B	-22.09%1.88B	-21.20%1.84B	72.79%3.84B	78.00%3.86B	9.80%2.42B
-Dividend payable	----	-97.04%41.9K	29,108.86%413.66M	-97.59%35.4K	--1.4M	--1.42M	--1.42M	--1.47M	----	----
-Other payable	----	----	----	-43.76%2.16B	----	-22.15%1.88B	----	72.72%3.83B	----	9.80%2.42B
Non current liabilities due within one year	48.42%790.41M	10.61%870.96M	-18.40%748.86M	-58.55%417.38M	-51.12%532.55M	-61.20%787.39M	-50.99%917.7M	-42.96%1.01B	-33.74%1.09B	-36.79%2.03B
Other current liabilities	-37.62%15.96M	-12.75%20.64M	3,130.06%926.48M	38.15%618.59M	-96.92%25.58M	-98.08%23.65M	-98.25%28.68M	-72.69%447.77M	-68.71%830.93M	-33.17%1.23B
Total current liabilities	-6.19%9.09B	-8.56%9.14B	6.35%10.14B	-21.19%9.63B	-25.52%9.69B	-17.44%9.99B	-22.29%9.54B	7.77%12.22B	5.18%13.01B	-9.73%12.1B
Current liabilities
Long term loan	-84.86%196M	-68.40%342M	-40.93%888.95M	-9.29%1.36B	-29.64%1.29B	-46.83%1.08B	-42.59%1.5B	-54.75%1.5B	-51.23%1.84B	-41.94%2.04B
Bonds payable	----	----	----	----	-99.91%1.71M	-41.31%1.57B	-29.68%1.92B	-29.65%1.9B	-27.51%1.94B	--2.67B
Estimate liabilities	115.63%3.04M	----	2.64%5.47M	-5.84%3.22M	-43.84%1.41M	--77.9K	--5.33M	--3.41M	--2.51M	----
Deferred tax liabilities	4.53%278.96M	0.75%266.09M	-14.24%272.9M	-17.59%268.67M	1.13%266.86M	-0.65%264.1M	24.10%318.21M	26.66%326.01M	1.59%263.87M	4.53%265.83M
Long term deferred income	3.26%299.51M	2.24%294.65M	22.20%292.04M	38.77%301.99M	43.46%290.06M	37.97%288.21M	16.50%238.98M	1.93%217.62M	-8.47%202.2M	-7.46%208.88M
Lease liabilities	104.57%525.26M	119.17%537.46M	140.72%558.84M	127.97%537.32M	2.96%256.77M	373.97%245.23M	615.92%232.16M	605.57%235.69M	1,512.49%249.39M	219.72%51.74M
Other non current liabilities	----	----	----	----	----	----	----	----	----	--0
Total non current liabilities	-38.31%1.3B	-58.21%1.44B	-52.12%2.02B	-40.86%2.48B	-53.04%2.11B	-34.12%3.45B	-27.81%4.22B	-35.88%4.19B	-35.24%4.5B	30.70%5.23B
Total liabilities	-11.93%10.4B	-21.29%10.58B	-11.57%12.16B	-26.21%12.11B	-32.59%11.8B	-22.47%13.44B	-24.07%13.75B	-8.18%16.41B	-9.35%17.51B	-0.43%17.33B
Shareholders equity
Paid-in capital	-0.22%1.6B	6.83%1.6B	8.58%1.6B	8.58%1.6B	8.86%1.6B	5.40%1.5B	4.10%1.48B	3.48%1.48B	3.22%1.47B	-0.22%1.42B
Other equity instruments	----	----	----	----	----	-43.38%170.22M	-32.19%210.06M	-32.19%210.07M	-30.17%216.34M	--300.63M
Capital reserve funds	-0.77%7.71B	25.85%7.73B	45.56%8.3B	115.98%8.28B	109.34%7.77B	67.27%6.14B	81.10%5.7B	11.89%3.83B	3.59%3.71B	2.56%3.67B
Surplus reserve funds	14.11%1.62B	14.11%1.62B	15.42%1.42B	15.42%1.42B	15.42%1.42B	15.41%1.42B	15.38%1.23B	15.38%1.23B	15.38%1.23B	15.38%1.23B
Retained profit	5.25%12.19B	9.94%11.6B	10.61%11.34B	14.10%11.08B	15.57%11.58B	14.88%10.55B	12.95%10.25B	13.82%9.71B	17.14%10.02B	11.19%9.19B
Less:Treasury stock	-38.34%131.7M	-10.83%191.83M	-10.40%192.98M	-10.40%192.98M	-9.90%213.61M	-9.25%215.14M	-27.43%215.38M	-52.88%215.38M	-40.73%237.08M	-40.73%237.08M
Other composite income	8.02%105.18M	14.34%112.99M	-63.08%84.9M	-51.22%118.97M	-12.26%97.38M	-37.92%98.82M	25.20%229.95M	587.72%243.89M	214.58%110.99M	305.45%159.19M
Specific reserves	-2.06%2.91M	-5.92%2.85M	--2.76M	--2.89M	--2.97M	--3.02M	----	----	----	----
Shareholders equity without minority interests	3.75%23.09B	14.27%22.48B	19.45%22.56B	35.30%22.31B	34.72%22.26B	25.03%19.67B	26.70%18.88B	15.00%16.49B	14.41%16.52B	13.55%15.73B
Minority interests	20.06%4.34B	27.38%4.26B	10.59%3.68B	80.70%3.62B	74.35%3.61B	194.11%3.34B	600.18%3.32B	458.48%2.01B	905.02%2.07B	316.97%1.14B
Total shareholder equity	6.02%27.43B	16.17%26.74B	18.12%26.23B	40.23%25.93B	39.13%25.87B	36.42%23.02B	44.40%22.21B	25.84%18.49B	26.95%18.6B	19.40%16.87B
Total liabilityies and equity	0.40%37.83B	2.36%37.32B	6.76%38.39B	8.99%38.04B	4.35%37.68B	6.57%36.45B	7.37%35.96B	7.17%34.9B	6.30%36.11B	8.45%34.21B
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)
Audit Opinions	--	Unqualified opinion	--	--	--	Unqualified opinion	--	--	--	Unqualified opinion
Auditor	--	Tianjian Certified Public Accountants (Special General Partnership)	--	--	--	Tianjian Certified Public Accountants (Special General Partnership)	--	--	--	KPMG Huazhen Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

002422 Sichuan Kelun Pharmaceutical

Sichuan Kelun Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Market Insights

Discussing

Latest News

Investment Course